- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/24 - Esteramides
Patent holdings for IPC class C07F 9/24
Total number of patents in this class: 374
10-year publication summary
|
30
|
23
|
29
|
31
|
20
|
15
|
19
|
29
|
21
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2060 |
22 |
| Cancer Targeted Technology LLC | 28 |
13 |
| Sony Group Corporation | 14299 |
10 |
| Sony Corporation | 30910 |
7 |
| Suzhou Abogen Biosciences Co., Ltd. | 75 |
7 |
| F. Hoffmann-La Roche AG | 7947 |
6 |
| Central Glass Company, Limited | 1274 |
6 |
| Medivir AB | 123 |
6 |
| The Johns Hopkins University | 5723 |
5 |
| UPL Limited | 597 |
5 |
| Zevra Therapeutics, Inc. | 101 |
5 |
| LG Chem, Ltd. | 17680 |
4 |
| Sony Corporation of America | 373 |
4 |
| The Regents of the University of California | 20137 |
4 |
| Centre National de La Recherche Scientifique | 10576 |
4 |
| Quiapeg Pharmaceuticals AB | 45 |
4 |
| Universite de Bretagne Occidentale | 109 |
4 |
| Washington State University | 487 |
4 |
| Arysta LifeScience Inc. | 69 |
4 |
| Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. | 6 |
4 |
| Other owners | 246 |